Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection L Townsend, AH Dyer, K Jones, J Dunne, A Mooney, F Gaffney, ... PloS one 15 (11), e0240784, 2020 | 938 | 2020 |
COVID19 coagulopathy in Caucasian patients H Fogarty, L Townsend, C Ni Cheallaigh, C Bergin, I Martin‐Loeches, ... British journal of haematology 189 (6), 1044-1049, 2020 | 565* | 2020 |
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 455 | 2021 |
Persistent poor health after COVID-19 is not associated with respiratory complications or initial disease severity L Townsend, J Dowds, K O’Brien, G Sheill, AH Dyer, B O’Kelly, JP Hynes, ... Annals of the American Thoracic Society 18 (6), 997-1003, 2021 | 326 | 2021 |
Persistent endotheliopathy in the pathogenesis of long COVID syndrome H Fogarty, L Townsend, H Morrin, A Ahmad, C Comerford, E Karampini, ... Journal of thrombosis and haemostasis 19 (10), 2546-2553, 2021 | 281 | 2021 |
Prolonged elevation of D‐dimer levels in convalescent COVID‐19 patients is independent of the acute phase response L Townsend, H Fogarty, A Dyer, I Martin‐Loeches, C Bannan, ... Journal of Thrombosis and Haemostasis 19 (4), 1064-1070, 2021 | 209 | 2021 |
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 133 | 2022 |
Age and frailty are independently associated with increased COVID-19 mortality and increased care needs in survivors: results of an international multi-centre study C Welch Age and ageing 50 (3), 617-630, 2021 | 121 | 2021 |
Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID‐19): evidence of acute and sustained endothelial cell activation SE Ward, GF Curley, M Lavin, H Fogarty, E Karampini, NL McEvoy, ... British journal of haematology 192 (4), 714-719, 2021 | 112 | 2021 |
Studying severe long COVID to understand post-infectious disorders beyond COVID-19 P Brodin, G Casari, L Townsend, C O’Farrelly, I Tancevski, J Löffler-Ragg, ... Nature medicine 28 (5), 879-882, 2022 | 105 | 2022 |
Fatigue following COVID-19 infection is not associated with autonomic dysfunction L Townsend, D Moloney, C Finucane, K McCarthy, C Bergin, C Bannan, ... PloS one 16 (2), e0247280, 2021 | 90 | 2021 |
Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection L Townsend, G Hughes, C Kerr, M Kelly, R O’Connor, E Sweeney, ... JAC-antimicrobial resistance 2 (3), dlaa071, 2020 | 79 | 2020 |
ADAMTS13 regulation of VWF multimer distribution in severe COVID‐19 SE Ward, H Fogarty, E Karampini, M Lavin, S Schneppenheim, R Dittmer, ... Journal of Thrombosis and Haemostasis 19 (8), 1914-1921, 2021 | 69 | 2021 |
Longitudinal analysis of COVID-19 patients shows age-associated T cell changes independent of ongoing ill-health L Townsend, AH Dyer, A Naughton, R Kiersey, D Holden, M Gardiner, ... Frontiers in immunology 12, 676932, 2021 | 48 | 2021 |
Sustained VWF‐ADAMTS‐13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction H Fogarty, SE Ward, L Townsend, E Karampini, S Elliott, N Conlon, ... Journal of Thrombosis and Haemostasis 20 (10), 2429-2438, 2022 | 45 | 2022 |
Clinical outcomes and adverse events in patients hospitalised with COVID‐19, treated with off‐label hydroxychloroquine and azithromycin M Kelly, R O'Connor, L Townsend, M Coghlan, E Relihan, M Moriarty, ... British journal of clinical pharmacology 87 (3), 1150-1154, 2021 | 45 | 2021 |
1-year quality of life and health-outcomes in patients hospitalised with COVID-19: a longitudinal cohort study K O’Brien, L Townsend, J Dowds, C Bannan, P Nadarajan, B Kent, ... Respiratory Research 23 (1), 115, 2022 | 41 | 2022 |
Kinetics of the severe acute respiratory syndrome coronavirus 2 antibody response and serological estimation of time since infection S Pelleau, T Woudenberg, J Rosado, F Donnadieu, L Garcia, T Obadia, ... The Journal of infectious diseases 224 (9), 1489-1499, 2021 | 36 | 2021 |
Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity N Smith, C Possémé, V Bondet, J Sugrue, L Townsend, B Charbit, ... Nature Communications 13 (1), 7254, 2022 | 35 | 2022 |
Investigating the relationship between vitamin D and persistent symptoms following SARS-CoV-2 infection L Townsend, AH Dyer, P McCluskey, K O’Brien, J Dowds, E Laird, ... Nutrients 13 (7), 2430, 2021 | 32 | 2021 |